Company intelligence / Profile preview

Triventures

Herzliya, Tel Aviv District, Israel

Ownership: Private
Development stage: Other

Overview

Triventures is not a product development company but an active early-stage venture capital fund, primarily investing in digital health, medical devices, and bio-convergence technologies, with more than 30 exits and a portfolio including synthetic biology, diagnostics, and genomics leaders[1][2][3][6].

Industry: Investors

Partnerships

Sheba Medical CenterPayGround & Fluidity-AI (portfolio collaboration)Lynx.MD & Prometheus Laboratories (portfolio collaboration)[1][2][3][7]Monogoto & Terrestar Solution (portfolio collaboration)[7]

Beyond the preview

Go deeper on Triventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triventures.

Explore the full profile